Propranolol and verapamil inhibit mRNA expression of RyR2 and SERCA in L-thyroxin-induced rat ventricular hypertrophy

Acta Pharmacologica Sinica

Volumn 25, Issue 3, 2004, Pages 347-351

  Wu, Xiao Dong ^a   Dai, De Zai ^a   Zhang, Qiu Pin ^b   Gao, Feng ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Arrhythmia; Ca 2+ transporting ATPase; Heart; Hypertrophy; L thyroxin; Propranolol; Reversed transcriptase polymerase chain reaction; Ryanodine receptors; Verapamil

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; LEVOTHYROXINE; MESSENGER RNA; PROPRANOLOL; RYANODINE RECEPTOR; VERAPAMIL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HEART ARRHYTHMIA; HEART HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; CALCIUM-TRANSPORTING ATPASES; CARDIOMEGALY; FEMALE; MALE; MYOCARDIUM; PROPRANOLOL; RANDOM ALLOCATION; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; THYROXINE; VERAPAMIL;

EID: 1542314289     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL, et al. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation 2001; 103: 2361-4
2. Wolk R. Arrhythmogenic mechanisms in left ventricular hypertrophy. Europace 2000; 2: 216-23.
3. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 2001; 88: 1159-67.
4. Schlotthauer K, Bers DM. Sarcoplasmic reticulum Ca(2+) release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials. Circ Res 2000; 87: 774-80.
5. Burashnikov A, Antzelevitch C. Acceleration induced action potential prolongation and early afterdepolarizations. J Cardiovasc Electrophysiol 1998; 9: 934-48.
6. Verduyn SC, Vos MA, Gorgels AP, van-der-Zande J, Leunissen JD, Wellens HJ. The effect of flunarizine and ryanodine on acquired torsades de pointes arrhythmias in the intact canine heart. J Cardiovasc Electrophysiol 1995; 6: 189-200.
7. Shannon TR, Ginsburg KS, Bers DM. Potentiation of fractional SR Ca release by total and free intra-SR Ca concentration. Biophys J 2000; 78: 334-43.
8. Lukyanenko V, Györke I, Györke S. Regulation of calcium release by calcium inside the sarcoplasmic reticulum in ventricular myocytes. Pflügers Arch 1996; 432: 1047-54.
9. Yoshida A, Takahashi M, Imagawa T, Shigekawa M, Takisawa H, Nakamura T. Phosphorylation of ryanodine receptors in rat myocytes during beta-adrenergic stimulation. J Biochem (Tokyo) 1992; 111: 186-90.
10. Yu F, Dai DZ, An LF, Guo XF. Heart hypertrophy induced by levothyroxine aggravate ischemic lesions and reperfusion arrhythmia in rats. Acta Pharmacol Sin 1997; 18: 71-4.
11. Dai DZ, Hu HJ, Yang DM. Chronic levothyroxin treatment is associated with ion channel abnormalities in cardiac and neuronal cells. Clin Exp Pharmacol Physiol 1999; 26: 819-20.
12. + current in guinea pig hypertrophied ventricular myocytes induced by the L-thyroxine. Chin Pharmacol Bull 2000; 17: 1-4.
13. Dai DZ, Zhang GQ, Yang P, Ma YP. Two patterns of ion channlopathies relating to arrhythmias and direct and indirect blockade of ion channels by antiarrhythmic agents. Drug Dev Res 2002; 57: 1-9.
14. Fitzsimmons TJ, Gukovsky I, McRoberts JA, Rodriguez E, Lai FA, Pandol SJ. Multiple isoforms of the ryanodine receptor are expressed in rat pancreatic acinar cells. Biochem J 2000; 351: 265-71.
15. Mirit E, Palmon A, Hasin Y, Horowitz M. Heat acclimation induces changes in cardiac mechanical performance: the role of thyroid hormone. Am J Physiol 1999; 276: R550-558.
16. Mark AR. Cardiac intracellular calcium release channels: role in heart failure. Circ Res 2000: 87: 8-11.
17. Meszaros J, Khananshvili D, Hart G. Mechanisms underlying delayed afterdepolarizations in hypertrophied left ventricular myocytes of rats. Am J Physiol Heart Circ Physiol 2001; 281: H903-14.
18. Sipido KR, Volders PG, de Groot SH, Verdonck F, Van de Werf F, Wellens HJ, et al. Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation 2000; 102: 2137-44.
19. 2+ sparks in cardiac myocytes by rapid scanning confocal microscopy: increase in amplitude by isoproterenol. Biochem Biophys Res Commun 1997; 233: 413-8.
20. Zhou XJ, Schluter KD, Piper HM. Hypertrophic responsiveness to beta 2-adrenoceptor stimulation on adult ventricular cardiomyocytes. Mol Cell Biochem 1996; 163-4: 211-6.